Cancer Disability Benefits

Overview

A cancer diagnosis can be devastating, and the physical toll of both the disease and its treatment frequently prevents people from working. The Social Security Administration recognizes this reality and evaluates cancer under Section 13.00 (Malignant Neoplastic Diseases) of the Blue Book. Many cancers qualify for SSDI or SSI disability benefits during the treatment period, and some — particularly aggressive or late-stage cancers — qualify automatically through the Compassionate Allowances program, which can approve applications in as few as 10 to 14 days.

The SSA evaluates cancer based on the type, location, extent (stage), and the effects of treatment. Even if your specific cancer is not listed in the Blue Book, you may still qualify based on the residual effects of treatment or the combination of your cancer with other impairments. For a general overview of the disability process, see our guide to understanding SSDI.

Cancers That Qualify for Disability

Section 13.00 of the Blue Book contains specific listings for cancers by organ system and type. The SSA evaluates cancer based on the origin, type, extent of involvement, duration, frequency and response to treatment, and effects of any post-therapeutic residuals. Key listings include:

This is not an exhaustive list. The SSA has specific listings for cancers of virtually every organ system. Even cancers not specifically listed can qualify if they cause functional limitations that prevent work, or if the effects of treatment (surgery, chemotherapy, radiation) are sufficiently debilitating. For details on how the Blue Book works, see our Blue Book listings guide.

Blue Book Criteria (Section 13.00)

The SSA evaluates cancer under Section 13.00 using specific criteria for each type. Several principles apply broadly across all cancer listings:

• Diagnosis must be confirmed: The SSA requires pathological (biopsy) confirmation of the malignancy, not just imaging or clinical suspicion. The pathology report must include the specific type and grade of cancer.
• Staging matters: More advanced cancers (higher stage) are more likely to meet a listing. The SSA uses the TNM staging system (Tumor, Node, Metastasis) for most solid tumors.
• Treatment effects count: Even if the cancer itself might not meet a listing, the debilitating effects of treatment — including fatigue, nausea, cognitive impairment ("chemo brain"), neuropathy, and immunosuppression — are considered.
• Duration requirement: The SSA requires that your condition is expected to last or has lasted at least 12 months, or is expected to result in death. Most active cancer treatment meets this requirement.
• Recurrence: Recurrent cancers after initial treatment often meet or equal a listing, even if the original cancer did not.

Compassionate Allowances Program

The Compassionate Allowances (CAL) program is one of the most important pathways for cancer patients seeking disability benefits. Established by the SSA, this program identifies conditions that are so severe that they obviously meet disability standards, allowing applications to be fast-tracked for approval. Over 80 types of cancer are on the Compassionate Allowances list, and processing times can be as short as 10 to 14 days from the date of application — compared to the typical 3 to 6 months.

You do not need to file a special application for Compassionate Allowances. When you submit your standard SSDI or SSI application, the SSA's electronic system automatically flags conditions that appear on the CAL list. However, it is critical that your application includes the specific diagnosis and pathology report so the system can correctly identify your condition. Listing your cancer in general terms (such as "cancer" rather than "pancreatic adenocarcinoma") could delay the CAL flag.

How SSA Evaluates Cancer Claims

The SSA evaluates cancer claims based on several key factors under the Section 13.00 guidelines. Understanding these factors can help you build a stronger application.

• Origin and type: Where the cancer originated and its histological type (confirmed by pathology/biopsy). This determines which specific listing applies.
• Extent of involvement: The stage of the cancer — including tumor size, lymph node involvement, and whether the cancer has metastasized to distant sites.
• Duration and frequency of treatment: Whether you are undergoing active treatment (surgery, chemotherapy, radiation, immunotherapy) and the expected duration.
• Response to treatment: Whether the cancer is responding to treatment, stable, progressing, or recurrent.
• Treatment side effects: The debilitating effects of cancer treatment, including fatigue, nausea, neuropathy, cognitive impairment, immunosuppression, and pain.

During and After Treatment

The SSA typically considers cancer patients disabled during active treatment when the treatment is expected to last at least 12 months. After treatment concludes, the evaluation shifts to whether you have residual limitations that prevent you from working. These may include:

• Permanent nerve damage (peripheral neuropathy from chemotherapy)
• Chronic fatigue and reduced stamina
• Cognitive changes ("chemo brain")
• Organ damage from treatment (heart, lungs, kidneys)
• Surgical residuals (loss of organ function, chronic pain)
• Psychological effects including depression, anxiety, and PTSD
• Lymphedema and chronic swelling
• Ongoing immunosuppression

If these residual effects prevent you from performing substantial gainful activity, you may continue to qualify for benefits even after the cancer itself is in remission.

Required Medical Evidence

Cancer claims require thorough medical documentation. The most critical piece of evidence is the pathology/biopsy report, which confirms the cancer diagnosis, type, and grade. Without this, the SSA cannot process your claim under the cancer listings.

Your oncologist should provide a detailed medical source statement describing your functional limitations during and after treatment. This is especially important if your cancer is in remission but you continue to experience significant residual effects. Learn more about evidence requirements in our guide to gathering medical evidence.

How to Strengthen Your Claim

• Apply as soon as possible: Do not wait until treatment is complete. Many cancer claims can be approved quickly, especially if your condition is on the Compassionate Allowances list.
• Include the pathology report: This is the single most important document. Without it, the SSA cannot evaluate your claim under the cancer listings.
• Use specific diagnostic language: Ensure your application uses the precise medical terminology for your cancer type, not general descriptions. This helps the SSA match your condition to the correct listing and identify Compassionate Allowances eligibility.
• Document all treatment effects: Ask your doctors to document every side effect and limitation caused by treatment. Fatigue, nausea, neuropathy, cognitive changes, and pain should all be in your medical records.
• Report all conditions: Cancer patients often have additional impairments — depression, anxiety, cardiovascular effects from treatment. Ensure all of these are documented and included in your application.
• Keep records of work impact: Document how your cancer and treatment prevent you from working, including missed work before you stopped, reduced productivity, and specific tasks you can no longer perform.
• Consider professional help: A disability attorney or advocate can help ensure your claim is complete and that critical medical evidence is presented properly. Most work on contingency.

If your initial application is denied — which is less common for cancer claims but can happen — do not give up. Learn about the appeals process after a denial to understand your options.